AstroBio CubeSat is a mission funded by the Italian Space Agency aimed at validating novel lab-on-chip technology, that would enable the use of micro- and nanosatellites as autonomous orbiting laboratories for research in astrobiology. This 3U CubeSat is equipped with a passive magnetic attitude control system (PMACS), including permanent magnets and hysteresis strips, which allows for stabilizing the spacecraft with the longitudinal axis in the direction of the geomagnetic field vector. This work presents the process followed for the experimental characterization of the system, performed on the engineering unit of the satellite by using a Helmholtz cage facility and a spherical air-bearing to recreate environmental conditions similar to the ones experienced during the orbital motion. The hysteresis strips are characterized starting from the determination of the hysteresis loop, from which the energy dissipation per cycle and the apparent magnetic permeability are extracted. Tests performed by using the Helmholtz cage and the air-bearing facility allows for further investigating the damping torque produced by the PMACS and validating the abovementioned parameters. Numerical analysis is then used to select the number of permanent magnets which allows for achieving a pointing accuracy within an error of ${10}^{\circ }$ within 24 h from the deployment. The analysis of the flight data supports the results obtained from the experimental test campaigns, confirming the effectiveness of the proposed methods and of the PMACS design.

One of the main challenges to be faced in deep space missions is to protect the health and ensure the maximum efficiency of the crew by preparing methods of prevention and in situ diagnosis. Indeed, the hostile environment causes important health problems, ranging from muscle atrophy, osteopenia, and immunological and metabolic alterations due to microgravity, to an increased risk of cancer caused by exposure to radiation. It is, therefore, necessary to provide new methods for the real-time measurement of biomarkers suitable for deepening our knowledge of the effects of space flight on the balance of the immune system and for allowing the monitoring of the astronaut’s health during long-term missions. APHRODITE will enable human space exploration because it fills this void that affects both missions in LEO and future missions to the Moon and Mars. Its scientific objectives are the design, production, testing, and in-orbit demonstration of a compact, reusable, and reconfigurable system for performing the real-time analysis of oral fluid samples in manned space missions. In the frame of this project, a crew member onboard the ISS will employ APHRODITE to measure the selected target analytes, cortisol, and dehydroepiandrosterone sulfate (DHEA-S), in oral fluid, in four (plus one additional desired session) separate experiment sessions. The paper addresses the design of the main subsystems of the analytical device and the preliminary results obtained during the first implementations of the device subsystems and testing measurements on Earth. In particular, the system design and the experiment data output of the lab-on-chip photosensors and of the front-end readout electronics are reported in detail along with preliminary chemical tests for the duplex competitive CL-immunoassay for the simultaneous detection of cortisol and DHEA-S. Different applications also on Earth are envisaged for the APHRODITE device, as it will be suitable for point-of-care testing applications (e.g., emergency medicine, bioterrorism, diagnostics in developing countries, etc.).